Danhof M[au] - Search Results

Year	Number of Results
1978	1
1979	5
1980	2
1981	1
1982	3
1983	1
1984	4
1985	6
1986	2
1987	3
1988	11
1989	8
1990	6
1991	18
1992	17
1993	6
1994	7
1995	13
1996	8
1997	22
1998	18
1999	12
2000	10
2001	5
2002	15
2003	13
2004	13
2005	19
2006	17
2007	26
2008	23
2009	18
2010	18
2011	17
2012	25
2013	24
2014	26
2015	24
2016	27
2017	16
2018	14
2019	3
2022	0

1

Pharmacokinetic interactions and dosing rationale for antiepileptic drugs in adults and children.

van Dijkman SC, Rauwé WM, Danhof M, Della Pasqua O. van Dijkman SC, et al. Among authors: danhof m. Br J Clin Pharmacol. 2018 Jan;84(1):97-111. doi: 10.1111/bcp.13400. Epub 2017 Nov 7. Br J Clin Pharmacol. 2018. PMID: 28815754 Free PMC article.

2

Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials.

van Dijkman SC, de Jager NCB, Rauwé WM, Danhof M, Della Pasqua O. van Dijkman SC, et al. Among authors: danhof m. Clin Pharmacokinet. 2018 Aug;57(8):1039-1053. doi: 10.1007/s40262-017-0614-5. Clin Pharmacokinet. 2018. PMID: 29363050

3

Advances in paediatric pharmacokinetics.

Knibbe CA, Krekels EH, Danhof M. Knibbe CA, et al. Among authors: danhof m. Expert Opin Drug Metab Toxicol. 2011 Jan;7(1):1-8. doi: 10.1517/17425255.2011.539201. Epub 2010 Nov 30. Expert Opin Drug Metab Toxicol. 2011. PMID: 21117982 Review.

4

[Individualized dosing guidelines for children].

Knibbe CA, Tibboel D, de Wildt SN, de Hoog M, Tjoeng MM, Danhof M. Knibbe CA, et al. Among authors: danhof m. Ned Tijdschr Geneeskd. 2013;157(16):A4214. Ned Tijdschr Geneeskd. 2013. PMID: 23594867 Review. Dutch.

5

Drug disposition in obesity: toward evidence-based dosing.

Knibbe CA, Brill MJ, van Rongen A, Diepstraten J, van der Graaf PH, Danhof M. Knibbe CA, et al. Among authors: danhof m. Annu Rev Pharmacol Toxicol. 2015;55:149-67. doi: 10.1146/annurev-pharmtox-010814-124354. Epub 2014 Oct 17. Annu Rev Pharmacol Toxicol. 2015. PMID: 25340929 Review.

6

Integration of PKPD relationships into benefit-risk analysis.

Bellanti F, van Wijk RC, Danhof M, Della Pasqua O. Bellanti F, et al. Among authors: danhof m. Br J Clin Pharmacol. 2015 Nov;80(5):979-91. doi: 10.1111/bcp.12674. Epub 2015 Jul 29. Br J Clin Pharmacol. 2015. PMID: 25940398 Free PMC article. Review.

7

Systems pharmacology - Towards the modeling of network interactions.

Danhof M. Danhof M. Eur J Pharm Sci. 2016 Oct 30;94:4-14. doi: 10.1016/j.ejps.2016.04.027. Epub 2016 Apr 27. Eur J Pharm Sci. 2016. PMID: 27131606 Free article. Review.

8

Ontogeny of hepatic glucuronidation; methods and results.

Krekels EH, Danhof M, Tibboel D, Knibbe CA. Krekels EH, et al. Among authors: danhof m. Curr Drug Metab. 2012 Jul;13(6):728-43. doi: 10.2174/138920012800840455. Curr Drug Metab. 2012. PMID: 22452455 Review.

9

Pharmacology-based toxicity assessment: towards quantitative risk prediction in humans.

Sahota T, Danhof M, Della Pasqua O. Sahota T, et al. Among authors: danhof m. Mutagenesis. 2016 May;31(3):359-74. doi: 10.1093/mutage/gev081. Epub 2016 Mar 12. Mutagenesis. 2016. PMID: 26970519 Review.

10

The future of drug development: the paradigm shift towards systems therapeutics.

Danhof M, Klein K, Stolk P, Aitken M, Leufkens H. Danhof M, et al. Drug Discov Today. 2018 Dec;23(12):1990-1995. doi: 10.1016/j.drudis.2018.09.002. Epub 2018 Sep 10. Drug Discov Today. 2018. PMID: 30213566 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results